Загрузка...
The resurgence of thyromimetics as lipid-modifying agents
Aggressive reduction of LDL cholesterol by the use of statins is a cornerstone of preventive cardiovascular care, but additional therapies to prevent atherosclerosis and its clinical sequelae are still needed. Thyromimetics selective for the liver or the thyroid hormone receptor isoform β1 constitut...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2993058/ https://ncbi.nlm.nih.gov/pubmed/19705333 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|